FLUARIXTETRA, quadrivalent seasonal influenza vaccine

INFECTIOUS DISEASE - New indication

Opinions on drugs - Posted on Dec 18 2018

Extension of indication

» FLUARIXTETRA now has MA for the prevention of seasonal influenza in infants and children, aged from 6 to 35 months.

» In this population, its efficacy and safety profile is comparable overall to that of trivalent influenza vaccines.

» This vaccine targets populations at a risk of severe forms of influenza.

Substantial

no clinical added value

Therapeutic use

All our publications

My account